GSE225900 HSDL2 knockdown 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE225900_HSDL2 knockdown_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE225900_HSDL2 knockdown_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE225900_HSDL2 knockdown_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE225900_HSDL2 knockdown_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

differentiation antagonizing non-protein coding RNA

Gene

deleted in lymphocytic leukemia 1

Gene

long intergenic non-protein coding RNA 857

Gene

ZFAND2A divergent transcript

Gene

uncharacterized LOC101928188

Gene

ATP6V0E2 antisense RNA 1

Gene

RHPN1 antisense RNA 1

Gene

TCF12 divergent transcript

Gene

uncharacterized LOC124904039

Gene

KAT7 pseudogene 1

  • Gene

    differentiation antagonizing non-protein coding RNA


  • Gene

    deleted in lymphocytic leukemia 1


  • Gene

    long intergenic non-protein coding RNA 857


  • Gene

    ZFAND2A divergent transcript


  • Gene

    uncharacterized LOC101928188


  • Gene

    ATP6V0E2 antisense RNA 1


  • Gene

    RHPN1 antisense RNA 1


  • Gene

    TCF12 divergent transcript


  • Gene

    uncharacterized LOC124904039


  • Gene

    KAT7 pseudogene 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.